Programmed death receptor ligand-2 (PD-L2) bearing extracellular vesicles as a new biomarker to identify early triple-negative breast cancer patients at high risk for relapse

por Hoffmann, Oliver, Wormland, Sebastian, Bittner, Ann-Kathrin, Collenburg, Monika, Horn, Peter A., Kimmig, Rainer, Kasimir-Bauer, Sabine, Rebmann, Vera
Publicado 2022

Elevated sHLA-G plasma levels post chemotherapy combined with ILT-2 rs10416697C allele status of the sHLA-G-related receptor predict poorest disease outcome in early triple-negativ...

por Hoffmann, Oliver, Wormland, Sebastian, Bittner, Ann-Kathrin, Hölzenbein, Julian, Schwich, Esther, Schramm, Sabine, Rohn, Hana, Horn, Peter A., Kimmig, Rainer, Kasimir-Bauer, Sabine, Rebmann, Vera
Publicado 2023